Rilpivirine is an antiretroviral medication used in the management of Human Immunodeficiency Virus (HIV) infection that prevents the replication of viruses. It reduces the number of viruses (viral load) in the body and keeps it at a low level.
It is always given in combination with other anti-retroviral medications (combination therapy).
It may also be given as post-exposure prophylaxis (PEP), which is a short course of combination of different anti-retroviral medications after a possible exposure to the virus. PEP should ideally be started within 72h after a possible exposure.
Common side effects include:
If any of the following effects persist or are severe, consult your doctor.
Rare but serious side effects include:
If you experience any of these symptoms, you should stop your medication and see your healthcare professional immediately.
Inform your healthcare professional if: